Michael Conte (San Francisco, USA) gives his thoughts on the recently released meta-analysis in JVIR, which has suggested an increased risk of death or amputation at 12 months when paclitaxel-coated balloons are used in the infrapopliteal arteries for the treatment of critical-limb threatening ischaemia (CLTI).
The new systematic review and study-level meta-analysis of eight randomised controlled trials was conducted by Konstantinos Katsanos (School of Medicine, University of Patras, Patras, Greece) and colleagues.
For in-depth analysis and commentary on this breaking story visit: https://vascularnews.com/meta-analysis-paclitaxel-katsanos/
Subscribe to receive BLearning videos here: https://blearning.net/registration/
Add comment